Abstract:Tau is a microtubule-associated protein with a diverse functional repertoire linked to neurodegenerative disease. Recently, a human tau knock-in (MAPT KI) mouse was developed that may overcome many limitations associated with current animal models used to study tau. In MAPT KI mice, the entire murine Mapt gene was replaced with the human MAPT gene under control of the endogenous Mapt promoter. This model represents an ideal in vivo platform to study the function and dysfunction of human tau protein. Accordingly, a detailed understanding of the effects MAPT KI has on structure and function of the CNS is warranted. Here, we provide a detailed behavioral and neuropathological assessment of MAPT KI mice. We compared MAPT KI to wild-type (WT) C57BL/6j mice in behavioral assessments of anxiety, attention, working memory, spatial memory, and motor performance from 6 to 24 months (m) of age. Using immunohistological and biochemical assays, we quantified markers of glia (microglia, astrocytes and oligodendrocytes), synaptic integrity, neuronal integrity and the cytoskeleton. Finally, we quantified levels of total tau, tau isoforms, tau phosphorylation, and tau conformations. MAPT KI mice show normal cognitive and locomotor behavior at all ages, and resilience to mild age-associated locomotor deficits observed in WT mice. Markers of neuronal and synaptic integrity are unchanged in MAPT KI mice with advancing age. Glial markers are largely unchanged in MAPT KI mice, but glial fibrillary acidic protein is increased in the hippocampus of WT and MAPT KI mice at 24 m. MAPT KI mice express all 6 human tau isoforms and levels of tau remain stable throughout adulthood. Hippocampal tau in MAPT KI and WT mice is phosphorylated at serine 396/404 (PHF1) and murine tau in WT animals displays more PHF1 phosphorylation at 6 and 12 m. Lastly, we extended previous reports showing that MAPT KI mice do not display overt pathology. No evidence of other tau phosphorylation residues (AT8, pS422) or abnormal conformations (TNT2 or TOC1) associated with pathogenic tau were detected. The lack of overt pathological changes in MAPT KI mice make this an ideal platform for future investigations into the function and dysfunction of tau protein in vivo.

Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted Tau and Map1b Genes.

Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization.

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.

Dysfunction of Microtubule-Associated Proteins of MAP2/tau Family in Prion Disease

Antagonistic Roles of Tau and MAP6 in Regulating Neuronal Development

Behavioral and neuropathological characterization over the adult lifespan of the human tau knock-in mouse

Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused By Loss Of App In Mouse Models

Abnormal brain development in mice lacking Tau and MAP1B

The disease-causing tau V337M mutation induces tau hypophosphorylation and perturbs axon morphology pathways

Tau Modulates Schwann Cell Proliferation, Migration And Differentiation Following Peripheral Nerve Injury

Microtubule-Associated Protein Tau Promotes Neuronal Class Ii -Tubulin Microtubule Formation And Axon Elongation In Embryonic Xenopus Laevis

Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice

Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy

A Genomic Sequence Analysis of the Mouse and Human Microtubule-Associated Protein Tau.

MAPT Mutations V337M and N297K Alter Organelle Trafficking in Frontotemporal Dementia Patient-Specific Motor Neurons

Projection Domains of MAP2 and Tau Determine Spacings Between Microtubules in Dendrites and Axons.

Ataxia And Purkinje Cell Degeneration In Mice Lacking The Camta1 Transcription Factor

CDKL5's role in microtubule-based transport and cognitive function

MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross‐seeding ability

Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies